Curis Lifesciences Ltd (CURIS) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow
Curis Lifesciences Ltd reported sales of ₹9.12 Cr, operating profit of ₹2.73 Cr (OPM 29.93%) and net profit of ₹1.2 Cr for the quarter ended Jun 2024. Figures in ₹ crore, consolidated where available.
| Metric | Jun 2024 |
|---|---|
| Sales | 9.12 |
| Expenses | 6.39 |
| Operating Profit | 2.73 |
| OPM | 29.93% |
| Other Income | 0 |
| Interest | 0.25 |
| Depreciation | 0.17 |
| Profit before tax | 2.31 |
| Tax | 48.05% |
| Net Profit | 1.2 |
| EPS in Rs | 24 |
| Metric | Mar 2023 | Mar 2024 |
|---|---|---|
| Sales | 35.42 | 35.58 |
| Expenses | 32.16 | 27.14 |
| Operating Profit | 3.26 | 8.44 |
| OPM | 9.2% | 23.72% |
| Other Income | 0.34 | 0.31 |
| Interest | 1.33 | 0.85 |
| Depreciation | 0.73 | 0.68 |
| Profit before tax | 1.54 | 7.22 |
| Tax | 20.13% | 25.9% |
| Net Profit | 1.23 | 5.36 |
| EPS in Rs | 24.6 | 107.2 |
| Dividend Payout | 0% | 0% |